10 Cathie Wood Pluristem Therapeutics Trades
The first Pluristem Therapeutics trade was made in Q4 2019. Since then Cathie Wood bought shares five more times and sold shares on four occasions. The investor sold all their shares in Q1 2022 and doesn't own any shares in Pluristem Therapeutics anymore.
Avg closing price
Price range
Sold -1.07 Million shares
Q1 2022
Avg closing price
$1.80
Price range
$1.42
-
$2.14
Increased shares by 15.8% (+147 Thousand shares)
Q4 2021
Avg closing price
$2.47
Price range
$1.46
-
$3.10
Sold 31.5% shares (-426 Thousand shares)
Q3 2021
Avg closing price
$3.20
Price range
$2.65
-
$3.96
Sold 62.4% shares (-2.24 Million shares)
Q2 2021
Avg closing price
$4.14
Price range
$3.54
-
$4.95
Sold 9.3% shares (-370 Thousand shares)
Q1 2021
Avg closing price
$6.55
Price range
$4.48
-
$8.49
Increased shares by 127.1% (+2.22 Million shares)
Q4 2020
Avg closing price
$9.11
Price range
$5.93
-
$11.46
Increased shares by 49.2% (+575 Thousand shares)
Q3 2020
Avg closing price
$9.56
Price range
$8.40
-
$11.48
Increased shares by 77.0% (+508 Thousand shares)
Q2 2020
Avg closing price
$8.17
Price range
$3.25
-
$12.43
Increased shares by 12.7% (+74.5 Thousand shares)
Q1 2020
Avg closing price
$3.74
Price range
$2.89
-
$4.66
New holding (+586 Thousand shares)
Q4 2019
Avg closing price
$3.58
Price range
$3.19
-
$4.21
News about Pluristem Therapeutics Inc and Cathie Wood
(Post 130/Yr 4 wk 41)Company Report:ARK Investment Management Daily Trades 7/1/2021
7/1/2021 Some notable stocks Pluristem therapeutic Pluristem Therapeutics, Inc. is a clinical stage company, which engages in cell therapy development. It de...
Cathie Woods ARK Invest Sells Over 60,000 Shares of Pluristem Therapeutics
No summary available.